# Akshat Kshetrapal

> Akshat Kshetrapal is a seed investor at DSM Venturing backing Health Care and Biopharma. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [DSM Venturing](https://shizune.co/investors/profile/dsm-venturing)
- Location: Amsterdam, The Netherlands
- Total investments: 3
- Last investment: Jan 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/akshatk/

Akshat Kshetrapal is a seed investor at DSM Venturing in Amsterdam focused on Health Care and Biopharma. Akshat Kshetrapal is the Investment Director at DSM Venturing.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biopharma | 1 | 33% |
| Organic Food | 1 | 33% |
| Biotechnology | 1 | 33% |
| Bioinformatics | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Denmark | 1 | 33% |
| The Netherlands | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $5.9M | Series A | Jan 22, 2026 |  |
| NutriLeads | NutriLeads is an innovative startup that develops nutritional ingredients with demonstrated health effects. NutriLeads aims to catalyze nutritional health innovation in the food industry by partnering with relevant companies to identify promising lead ingredients, develop sustainable and commercially viable production processes, and initiatescientific & clinical programs to substantiate the health effects of these ingredients. Together we will bring the benefits of the proprietary ingredients to patients and consumers. | $4.9M | Series C | Dec 18, 2023 |  |
| Octarine Bio | Octarine Bio is a synthetic biology company that produces superior cannabinoids for the pharmaceutical industry. | $2M | Seed | Sep 20, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [Oskare Capital](https://shizune.co/investors/profile/oskare-capital) — VC Fund, 2 deals together
- [Edaphon](https://shizune.co/investors/profile/edaphon) — VC Fund, 1 deal together
- [The Footprint Firm](https://shizune.co/investors/profile/the-footprint-firm) — VC Fund, 1 deal together
- [Unconventional Ventures](https://shizune.co/investors/profile/unconventional-ventures-0eb1) — VC Fund, 1 deal together

## About DSM Venturing

VC Fund · Heerlen, The Netherlands

Founded in 2002, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

5 contacts available at DSM Venturing.

| Name | Title | Profile |
| --- | --- | --- |
| Akshat Kshetrapal | Investment Director | https://shizune.co/investors/profile/akshat-kshetrapal-bfc7 |
| Arpesh Mehta | Investment Director | https://shizune.co/investors/profile/arpesh-mehta |
| Greg McParland | Investment Director | https://shizune.co/investors/profile/greg-mcparland |
| Iulian Baxan | Analyst | https://shizune.co/investors/profile/iulian-baxan |
| Luda Kopeikina | Investment Director | https://shizune.co/investors/profile/luda-kopeikina |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Akshat Kshetrapal invest in?

Akshat Kshetrapal invests primarily in Health Care, Biopharma and Organic Food startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Akshat Kshetrapal last invest?

The most recent investment recorded for Akshat Kshetrapal closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co